Vestcor Inc Has $4.17 Million Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Vestcor Inc lowered its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 12.4% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 8,478 shares of the medical equipment provider’s stock after selling 1,200 shares during the period. Vestcor Inc’s holdings in Intuitive Surgical were worth $4,165,000 as of its most recent SEC filing.

Other institutional investors have also recently bought and sold shares of the company. Mirador Capital Partners LP boosted its stake in Intuitive Surgical by 1.4% during the third quarter. Mirador Capital Partners LP now owns 3,526 shares of the medical equipment provider’s stock worth $1,732,000 after buying an additional 50 shares in the last quarter. Consolidated Planning Corp boosted its stake in Intuitive Surgical by 17.4% during the third quarter. Consolidated Planning Corp now owns 8,099 shares of the medical equipment provider’s stock worth $3,979,000 after buying an additional 1,198 shares in the last quarter. Healthcare of Ontario Pension Plan Trust Fund lifted its holdings in shares of Intuitive Surgical by 617.1% during the second quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 89,069 shares of the medical equipment provider’s stock valued at $39,622,000 after acquiring an additional 76,649 shares during the period. Swiss National Bank lifted its holdings in shares of Intuitive Surgical by 0.3% during the third quarter. Swiss National Bank now owns 1,052,800 shares of the medical equipment provider’s stock valued at $517,209,000 after acquiring an additional 3,400 shares during the period. Finally, ABLE Financial Group LLC bought a new position in shares of Intuitive Surgical during the third quarter valued at $604,000. Institutional investors and hedge funds own 83.64% of the company’s stock.

Insider Transactions at Intuitive Surgical

In other news, CFO Jamie Samath sold 108 shares of the stock in a transaction that occurred on Tuesday, November 26th. The stock was sold at an average price of $542.06, for a total value of $58,542.48. Following the completion of the sale, the chief financial officer now owns 8,757 shares of the company’s stock, valued at approximately $4,746,819.42. This represents a 1.22 % decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, Director Amy L. Ladd sold 450 shares of the stock in a transaction that occurred on Friday, September 13th. The shares were sold at an average price of $490.28, for a total value of $220,626.00. Following the completion of the sale, the director now directly owns 821 shares of the company’s stock, valued at approximately $402,519.88. The trade was a 35.41 % decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders sold 50,485 shares of company stock worth $26,128,102. 0.90% of the stock is currently owned by company insiders.

Wall Street Analyst Weigh In

ISRG has been the subject of a number of analyst reports. Wells Fargo & Company lifted their price objective on Intuitive Surgical from $466.00 to $549.00 and gave the company an “overweight” rating in a report on Friday, October 18th. Royal Bank of Canada lifted their price objective on Intuitive Surgical from $525.00 to $555.00 and gave the company an “outperform” rating in a report on Friday, October 18th. Piper Sandler reissued an “overweight” rating and set a $538.00 price objective (up from $495.00) on shares of Intuitive Surgical in a report on Friday, October 18th. Morgan Stanley raised Intuitive Surgical from an “equal weight” rating to an “overweight” rating and lifted their price target for the company from $522.00 to $650.00 in a report on Monday, December 2nd. Finally, Robert W. Baird lifted their price target on Intuitive Surgical from $503.00 to $565.00 and gave the company an “outperform” rating in a report on Thursday, October 17th. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating and fifteen have given a buy rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $541.33.

Intuitive Surgical Trading Down 0.1 %

Shares of NASDAQ:ISRG opened at $538.09 on Wednesday. The stock has a market capitalization of $191.66 billion, a P/E ratio of 86.51, a P/E/G ratio of 5.41 and a beta of 1.38. Intuitive Surgical, Inc. has a 1-year low of $309.80 and a 1-year high of $556.23. The business has a 50-day moving average price of $517.16 and a two-hundred day moving average price of $475.65.

Intuitive Surgical (NASDAQ:ISRG) last posted its earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.24 by $0.32. The company had revenue of $2.04 billion during the quarter, compared to analyst estimates of $2.01 billion. Intuitive Surgical had a return on equity of 13.41% and a net margin of 28.51%. As a group, equities analysts predict that Intuitive Surgical, Inc. will post 5.45 EPS for the current year.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.